Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Condition(s):BotulismLast Updated:December 4, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):BotulismLast Updated:December 4, 2018Withdrawn
Condition(s):Plague VaccineLast Updated:July 30, 2020Completed
Condition(s):Botulism VaccineLast Updated:December 2, 2011Completed
Condition(s):Healthy VolunteersLast Updated:December 2, 2011Completed
Condition(s):Venezuelan Equine EncephalitisLast Updated:September 18, 2015Withdrawn
Condition(s):RECOMBINANT BOTULINUM VACCINE A/BLast Updated:August 23, 2012Completed
Condition(s):Pneumonic Plague; Preventive TherapyLast Updated:June 30, 2011Completed
Condition(s):AnthraxLast Updated:June 30, 2011Completed
Condition(s):SmallpoxLast Updated:June 30, 2011Completed
Condition(s):Healthy VolunteersLast Updated:May 5, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.